Publisher: Adis International
ISSN: 0114-9954
Source: Reactions Weekly, Vol.1, Iss.1212, 2008-01, pp. : 5-5
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Adalimumab/infliximab: First report of pseudolymphoma: case report
Reactions Weekly, Vol. 1, Iss. 1401, 2012-01 ,pp. :
Adalimumab/infliximab: Psoriasis: case report
Reactions Weekly, Vol. 1, Iss. 1350, 2011-01 ,pp. :
Adalimumab: Giant cell arteritis (first report) in an elderly patient: case report
Reactions Weekly, Vol. 1, Iss. 1168, 2007-01 ,pp. :
Adalimumab/infliximab: Stress fracture (first report with infliximab): 2 case reports
Reactions Weekly, Vol. 1, Iss. 1100, 2006-01 ,pp. :
Adalimumab/infliximab: Cutaneous leishmaniasis: case report
Reactions Weekly, Vol. 1, Iss. 1187, 2008-01 ,pp. :